IEX Stock Chart & Stats
$3105.00
$0.00(0.00%)
At close: 4:00 PM EDT
$3105.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2,964.01 - $3,960.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$278.95B
Enterprise Value$18.10K
Total Cash (Recent Filing)$621.30M
Total Debt (Recent Filing)$1.89B
Price to Earnings (P/E)32.4
Beta0.05
Next Earnings
Oct 27, 2026EPS Estimate
37.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.97
Shares Outstanding73,719,894
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-7.12
Price to Book (P/B)3.33
Price to Sales (P/S)3.88
P/FCF Ratio21.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4,484.80Price Target Upside44.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)148.97
Revenue Forecast (FY)$62.44B
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation And Earnings QualityIDEX converts reported earnings into substantial cash, giving the company flexibility to reinvest, support working capital, pursue bolt-on acquisitions, and return capital. This level of conversion strengthens financial resilience and makes growth less dependent on external financing over the next several quarters.
Growing Orders, Backlog Visibility, And Raised GuidanceRecord orders and expanding backlog provide evidence of demand extending beyond a single quarter, particularly in selected advantaged markets. Combined with higher full-year organic growth, EBITDA margin, and EPS guidance, this supports a stronger medium-term revenue and earnings outlook.
Diversified, Differentiated Mission-critical Product PortfolioThe portfolio spans multiple end markets and focuses on engineered components used in mission-critical applications, which can support customer retention and performance-based pricing. Diversification across fluid handling, health sciences, and safety also reduces reliance on one industry cycle.
Bears Say
Margins And Returns Remain Below Prior PeaksAlthough profitability remains solid, the sustained step-down from 2022–2023 peak margins indicates that pricing, product mix, or cost pressures have reduced earnings efficiency. Lower margins and ROE could constrain future compounding unless operational improvements restore prior profitability levels.
Weakness And Mix Pressure In FMT And FSDPTwo operating segments are experiencing limited sales growth or declines despite stronger orders, while unfavorable mix and volume deleverage are pressuring margins. If this pattern persists, it could offset HST momentum and make consolidated growth and profitability more uneven.
Industrial And Geographic Demand UncertaintyCautious customers and weaker conditions in China and selected industrial markets could delay equipment purchases and temper short-cycle demand. This creates a risk that order strength will convert into revenue more slowly, while regional and end-market variability complicates sustained organic growth.
IDEX News
IEX FAQ
What was IDEX Corporation’s price range in the past 12 months?
IDEX Corporation lowest stock price was $2964.01 and its highest was $3960.00 in the past 12 months.
What is IDEX Corporation’s market cap?
IDEX Corporation’s market cap is $278.95B.
When is IDEX Corporation’s upcoming earnings report date?
IDEX Corporation’s upcoming earnings report date is Oct 27, 2026 which is in 48 days.
How were IDEX Corporation’s earnings last quarter?
IDEX Corporation released its earnings results on Jul 29, 2026. The company reported $39.236 earnings per share for the quarter, beating the consensus estimate of $35.634 by $3.602.
Is IDEX Corporation overvalued?
According to Wall Street analysts IDEX Corporation’s price is currently Undervalued.
Does IDEX Corporation pay dividends?
IDEX Corporation does not currently pay dividends.
What is IDEX Corporation’s EPS estimate?
IDEX Corporation’s EPS estimate is 37.82.
How many shares outstanding does IDEX Corporation have?
IDEX Corporation has 73,719,894 shares outstanding.
What happened to IDEX Corporation’s price movement after its last earnings report?
IDEX Corporation reported an EPS of $39.236 in its last earnings report, beating expectations of $35.634. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of IDEX Corporation?
Currently, no hedge funds are holding shares in MX:IEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDEX Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4,484.80 (44.44% Upside)
$4,484.80 (44.44% Upside)
Blogger Sentiment
Neutral
MX:IEX Sentiment 80%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.49%
12-Months-Change
Fundamentals
Return on Equity
1.28%
Trailing 12-Months
Asset Growth
0.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
IDEX Corporation
IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.
IEX Company Deck
IEX Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong underlying operational performance and demand momentum, with multiple material positives: organic revenue and EPS growth, significant order expansion (28% overall; HST 47%), margin expansion, record orders and improved leverage and cash generation. Management raised full-year guidance and endorsed continued share repurchases while increasing targeted CapEx to support visible future volumes. Key headwinds were limited: segment-level softness in FMT and FSDP (small or single-digit revenue impacts and margin compression from mix/volume deleverage), and a one-time reporting effect from tariff refunds that reduced reported organic growth by ~2% but provided margin/earnings benefit. Overall the positives materially outweigh the challenges.View all MX:IEX earnings summariesIEX Net sales Breakdown
35.36% Fluid & Metering Technologies
43.11% Health & Science Technologies
21.53% Fire & Safety/Diversified Products
IEX Stock 12 Month Forecast
Average Price Target
$4,484.80
▲(44.44% Upside)